CHATTERJEE SANKAR,DIEBOLD JAMES L.,DUNN DEREK,HUDKINS ROBERT L.,DANDU REDDEPPAREDDY,WELLS GREGORY J.,ZULLI ALLISON L.,CHATTERJEE Sankar,DIEBOLD James L.,DUNN Derek,HUDKINS Robert L.,DANDU Reddeppareddy,WELLS Gregory J
申请号：
SI200731252
公开号：
SI2066324T1
申请日:
2007.06.19
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
